Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2010
06/16/2010CN101735993A Method for efficiently producing cellulase
06/16/2010CN101735992A Exogenous composite enzyme preparation special for feed industry and preparation method and application thereof
06/16/2010CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/16/2010CN101735967A Organic solvent resisting lipase, application thereof and bacteria for producing same
06/16/2010CN101732717A Ttk in diagnosis and as a therapeutic target in cancer
06/16/2010CN101215538B Bacillus licheniformis and application thereof
06/16/2010CN101215537B 地衣芽孢杆菌及其应用 Bacillus and Its Applications
06/16/2010CN101210252B Lepidoptera pest ground substance metalloprotein gene mmp and application thereof
06/15/2010US7737330 a polynucleotide comprising a nucleotide sequence or complement encoding a polypeptide comprising a farnesyltranstransferase beta subunit, used to improve tolerance to drought in mature plants
06/15/2010US7737325 non-human knock-out mammal lacking alpha-1,6-fucosylation, comprising an exogenous gene encoding an antibodies comprising an Fc region bound to a complex N-glycoside-linked sugar chains comprising a reducing end which contains an N-acetylglucosamine
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737240 for cells, proteins, DNA or other molecules encapsulation; carragenan, chitosan, hyaluronic acid, cellulose or alginate; with thiophene, aniline or pyrrole polymerizable moiety grafted on
06/15/2010US7736884 biosynthesis of arachidonic acid, eicosapentaenoic acid and/or docosahexaenoic acid, from non-fatty acid substrates through heterologous gene expression of an oxygen requiring pathway in microorganisms
06/15/2010US7736882 biosynthesis of isopentenyl pyrophosphate, terpenes and steroids, using cultures of transformed microorganisms comprising nucleotide sequences that code mevalonate pathway enzymes
06/15/2010US7736881 Antibacterial and herbicidal compounds and system for screening the same
06/15/2010US7736878 Recombinant forms of DNA sequences for a cyclobutane pyrimidine dimer (CPD) glycosylase protein, that are capable of expression at high level, used in topical formulations for treatment of photosensitive or autoimmune disease that are exacerbated by DNA damage from UV light exposure, such as lupus
06/15/2010US7736876 Peptide-forming enzyme gene
06/15/2010US7736875 Dipeptidyl peptidase I crystal structure and its uses
06/15/2010US7736872 cells comprising a translation system comprising an synthetase enzymes encoded by a nucleotide sequence and the complementary polynucleotide sequence; protein biosynthesis
06/15/2010US7736871 Nucleotide sequences coding dipeptide forming enzyme
06/15/2010US7736680 Using mutations to improve Aspergillus phytases
06/15/2010US7736643 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry
06/15/2010CA2322729C Modification of fatty acid metabolism in plants
06/15/2010CA2319658C Continuous fermentation process
06/15/2010CA2285939C Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/15/2010CA2284119C Phosphatidyl-3,4,5-triphosphate-dependent protein kinase
06/15/2010CA2269109C Protease for activating clotting factor vii
06/15/2010CA2250000C Methods of modulating melanin synthesis
06/10/2010WO2010065830A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010WO2010065448A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/10/2010WO2010064897A1 Farmesene synthase
06/10/2010WO2010064598A1 Mutant gluconate dehydrogenase
06/10/2010WO2010064243A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
06/10/2010WO2010064142A1 Screening method for the identification of inhibitors of viral entry
06/10/2010WO2010064132A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation
06/10/2010WO2010063783A2 Modulating XRN2
06/10/2010WO2010063718A1 Screening assay for metabolic disease therapeuticals
06/10/2010WO2010063172A1 An elp fusion protein and uses thereof
06/10/2010WO2010031772A3 Alternative butanol production process in a microbial cell
06/10/2010WO2010029378A3 Anti-protozoa compounds
06/10/2010WO2009133462A3 Proteins
06/10/2010WO2009127969A3 Process
06/10/2010WO2009021867A9 Agents containing proteases
06/10/2010US20100146665 Increased Stress Tolerance and Enhanced Yield in Plants
06/10/2010US20100146651 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
06/10/2010US20100146642 Methods and compositions relating to PBK1
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100144893 Isoprenoid synthases
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144841 Control of nk cell function and survival by modulation of ship activity
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144739 Heterocyclic inhibitors of c-met and uses thereof
06/10/2010US20100144721 Inhibitors of c-met and uses thereof
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144575 Alpha-Amylase Mutants
06/10/2010US20100144013 Over expression of foldases and chaperones improves protein production
06/10/2010US20100144012 A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y; for genome engineering and gene therapy
06/10/2010US20100144011 Crystal growth under microgravity condition
06/10/2010US20100144010 Enzymatic Asymmetric Decarboxylation of Disubstituted Malonic Acids
06/10/2010US20100144009 Extracting And Purifying Lipoxygenase
06/10/2010US20100144008 Treatment of fabry disease
06/10/2010US20100143997 Engineered microorganisms capable of producing target compounds under anaerobic conditions
06/10/2010US20100143986 R-hnl random variants and their use for preparing optically pure, sterically hindered cyanohydrins
06/10/2010US20100143979 Polypeptides having dna polymerase activity
06/10/2010US20100143970 Transglutaminase having disulfide bond introduced therein
06/10/2010US20100143969 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
06/10/2010US20100143968 Penicillin-g acylases
06/10/2010US20100143967 Compositions and methods for enhancing the degradation or conversion of cellulose-containing material
06/10/2010US20100143942 Method of detection
06/10/2010US20100143940 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics
06/10/2010US20100143500 Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143436 Self-assembly of protein-based biomaterials with multiple morphologies
06/10/2010US20100143411 Method for identification of t-lymphocyte antigens
06/10/2010US20100143388 comprise a Fc region comprising complex N-glycoside-linked sugar chains bound to the Fc region; useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143330 Methods of treating disorders associated with fat storage
06/10/2010US20100143323 Modified phosphatases
06/10/2010US20100143316 Novel strain of bacillus amyloliquefaciens and its use
06/10/2010US20100143308 Akt nucleic acids, polypeptides, and uses thereof
06/10/2010US20100143300 Hepatitis c therapies
06/10/2010US20100143291 Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
06/10/2010CA2745853A1 Farnesene synthase
06/10/2010CA2745760A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010CA2745608A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/10/2010CA2745205A1 Glutamyl trna synthetase (gts) fragments
06/09/2010EP2194139A1 Biochemical synthesis of 6 amino caproic acid
06/09/2010EP2194133A2 Amylases, nucleic acids encoding them and methods for making and using them
06/09/2010EP2194124A1 Protein kinase c peptide modulators of angiogenesis
06/09/2010EP2194123A1 DNA polymerase fusions and uses thereof
06/09/2010EP2194122A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
06/09/2010EP2194119A2 Production of fatty acids and derivatives thereof
06/09/2010EP2193804A2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens
06/09/2010EP2193198A2 Amidohydrolases for preparing foodstuffs or stimulants
06/09/2010EP2193197A2 Process for purification of human tissue type plasminogen activator
06/09/2010EP2193194A1 Method for producing 2-methyl-1,2-dihydroxypropane
06/09/2010EP1721973B1 Mutant bacterium belonging to the genus bacillus
06/09/2010EP1685248B1 Oxidoreductase from metschnikowia zobellii
06/09/2010EP1653990B1 Use of polypeptides of the cupredoxin family in cancer therapy
06/09/2010EP1335981B1 18480 human protein kinase molecules and uses therefor